3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
11
Prostatic Neoplasms
7
Neoplasm Metastasis
5
Ovarian Neoplasms
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Endometrial Neoplasms
3
Small Cell Lung Carcinoma
2
Fallopian Tube Neoplasms
2
mCRPC
1
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Pheochromocytoma
1
Pathologic Complete Response
1
Paraganglioma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Interventions
ruxolitinib
7
fludarabine phosphate
3
bomedemstat
3
Whole-Body Irradiation
3
Tacrolimus
3
Specimen Handling
3
Mycophenolic Acid
3
Cyclophosphamide
3
Biopsy
3
fludarabine
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Melphalan
2
Injections
2
Busulfan
2
venetoclax
1
veliparib
1
piperine
1
pevonedistat
1
iadademstat
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
anagrelide
1
X-Rays
1
Valganciclovir
1
Transplantation
1
Topotecan
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
talazoparib
×
1 year
×
Clear all
No trials found.